News

RSS
In vivo CAR-M: Strike Pharma files patent on T cell-depleting STR-2
Strike Pharma AB Original source

A lipid nanoparticle that turns circulating monocytes into CAR-macrophages, pointed at the T cells driving autoimmune disease rather than the B cells in vivo CAR work has targeted so far. Strike Pharma has filed on STR-2 and named four candidate indications.

Vinnova life science call puts 3 MSEK behind joint projects

Vinnova is backing joint life science projects with up to 3 million SEK apiece, the first money out of a government programme that also funds CCRM Nordic. Applications need three independent parties, including a company and a university, and close on 9 February 2027.

CAR-T grant to Elicera co-founder targets solid tumour persistence

Vetenskapsrådet has put SEK 4 million behind a four-year attempt to settle how much baseline activity a CAR-T receptor needs in order to penetrate a solid tumour. The project is led by Elicera Therapeutics co-founder Di Yu at Uppsala University.

Testa Center access grant part-funds bioprocess scale-up weeks

Bioprocess development at Testa Center in Uppsala is now part-funded again: up to five weeks of access per project, with 70 percent of the access fee covered for academic projects and 50 percent for companies. Weeks are allocated first come, first served and must be used by 30 April 2027.

Sahlgrenska to establish pre-GMP laboratory for ATMP developers
Sahlgrenska Universitetssjukhuset Sahlgrenska Universitetssjukhuset Original source

A pre-GMP laboratory in Western Sweden will let ATMP developers prove out their manufacturing processes before committing to a GMP facility. It is one of two resources in Precisionsplattformen, backed by SEK 25 million in EU regional development and Västra Götalandsregionen funding.

IVA ATMP report: what Sweden must fix to stay competitive
Royal Swedish Academy of Engineering Sciences (IVA) Original source

The Royal Swedish Academy of Engineering Sciences has set out what Sweden needs to change to hold its position in advanced therapies. The IVA ATMP report asks for three national super-ecosystems, a transferable fast-track voucher at EU level and clearer national guidance on the hospital exemption.

2026-04-23 Jobs, Careers & Opportunities

Join the ESGCT ECR Board – Apply by 15 May 2026

Join the ESGCT ECR Board – Apply by 15 May 2026

The European Society of Gene and Cell Therapy is looking for its next ECR Board Member. Are you a PhD student or post-doc in gene and cell therapy? Applications close 15 May 2026.

Doctoral Course: From Research to ATMP Treatment
Flemingsberg Science Foundation natasha.bank@flemingsbergscience.se

Doctoral Course: From Research to ATMP Treatment

BioLamina secures €20M to scale cell therapy tech

EIB backs Swedish biotech scale-up BioLamina with €20 million to enable stem cell technologies targeting diseases such as type 1 diabetes, Parkinson’s disease, and heart failure

Doctoral course: From Research to ATMP Treatment 
Karolinska Institutet Original source

Karolinska Institutet offers a two-week doctoral course designed to provide a comprehensive overview of the entire process involved in developing and producing cell and gene therapy products.

Towards a Swedish Centre of Excellence in Bioanalytics: Introducing BACE

Sweden is strengthening its position in advanced bioanalytics with the launch of the BioAnalytical Cluster of Excellence (BACE), supported by Vinnova.

2026-03-02 Events & Conferences

ATMP Manufacturing Course – April 2026

ATMP Manufacturing Course – April 2026

Want to strengthen your expertise in hospital-based ATMP and cell therapy manufacturing? This three-day course in April 2026 offers practical insight into regulation, quality systems and clinical application.

Read all news